Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Paul Hartmann AG
PHH2Paul Hartmann AG manufactures and sells medical and care products in Germany, rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Incontinence Management, Wound Care, and Infection Management. It offers body-absorbent products and traditional and modern wound dressings. In addition, the company produce single-use products and solutions for infection; hand, surface, and instrument disinfection; and cleaning, skin care, and skin antisepsis. Further, it offers Link, a platform to learn and exchange medical and clinical knowledge. It sells its products through pharmacies, medical supply stores, and online channels. The company was founded in 1818 and is headquartered in Heidenheim, Germany. Address: Paul-Hartmann-Strasse 12, Heidenheim, Germany, 89522
Analytics
Zielpreis von Wall Street
–KGV
11.6945Dividendenrendite
4.07 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen PHH2
Dividenden-Analyse PHH2
Dividendenwachstum über 5 Jahre
14 %Kontinuierliches Wachstum
–Ausschüttungsquote 5-Jahres-Durchschnitt
55 %Verlauf der Dividende PHH2
Bewertung der Aktie PHH2
Finanzen PHH2
Ergebnisse | 2019 | Dynamik |